Valuation Caplin Point Laboratories Limited NSE India S.E.

Stocks

Delayed NSE India S.E. Other stock markets 04:42:52 2026-07-02 am EDT			5-day change	1st Jan Change
2,525.00 ^INR	-1.52%		+0.74%	+37.37%

May. 14	Caplin Point Laboratories Limited, Q4 2026 Earnings Call, May 14, 2026
May. 14	Caplin Point Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	30,571	51,529	45,291	100,038	152,221	194,753	-	-
Change	-	68.55%	-12.11%	120.88%	52.16%	27.94%	-	-
Enterprise Value (EV)	30,571	51,529	45,291	100,038	152,221	194,753	194,753	194,753
Change	-	68.55%	-12.11%	120.88%	52.16%	27.94%	0%	0%
P/E	12.7x	17.3x	12.1x	22x	28.5x	17.9x	27.3x	24x
PBR	2.58x	3.47x	2.41x	4.32x	5.34x	3.19x	4.42x	4.02x
PEG	-	0.7x	0.5x	1x	1.6x	0.9x	1.7x	1.7x
Capitalization / Revenue	2.88x	4.06x	3.09x	5.91x	7.86x	5.23x	7.83x	6.94x
EV / Revenue	0x	0x	0x	0x	0x	9.15x	7.83x	6.94x
EV / EBITDA	0x	0x	0x	0x	0x	26.3x	22.6x	19.9x
EV / EBIT	0x	0x	0x	-	0x	25x	20.9x	18.1x
EV / FCF	0x	0x	0x	0x	0x	51.3x	35.4x	36x
FCF Yield	6.39%	4.77%	1.72%	1.73%	1.58%	2.4%	2.82%	2.78%
Dividend per Share ²	3	2	2	2.5	3	-	4	4
Rate of return	0.74%	0.29%	0.34%	0.19%	0.15%	-	0.16%	0.16%
EPS ²	31.71	39.26	49.18	59.9	70.25	84.11	93.8	107
Distribution rate	9.46%	5.09%	4.07%	4.17%	4.27%	-	4.26%	3.74%
Net sales ¹	10,613	12,694	14,667	16,941	19,375	21,872	24,880	28,053
EBITDA ¹	3,286	3,947	4,411	5,514	6,469	7,609	8,604	9,810
EBIT ¹	3,152	3,478	4,520	-	5,810	8,036	9,321	10,752
Net income ¹	2,423	2,998	3,763	4,571	5,363	6,412	7,128	8,124
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	404.15	679.90	596.70	1,317.30	2,002.60	2,562.15	2,562.15	2,562.15
Nbr of stocks (in thousands)	75,643	75,789	75,903	75,942	76,012	76,012	-	-
Announcement Date	5/6/21	5/12/22	5/27/23	5/16/24	5/15/25	5/14/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	38.49x	7.3x	24.89x	0.81%	47.1B
OTSUKA HOLDINGS CO., LTD.	17.73x	1.99x	9.41x	1.36%	34.57B
CIPLA LIMITED	28.05x	3.47x	17.77x	0.86%	12.38B
ZYDUS LIFESCIENCES LIMITED	24.33x	4.21x	15.68x	0.73%	11.64B
KRKA, D. D.	19.29x	3.32x	12.08x	3.54%	8.87B
GEDEON RICHTER	8.47x	1.99x	5.22x	5.12%	7.1B
ONO PHARMACEUTICAL CO., LTD.	15.95x	2.02x	6.81x	3.31%	6.85B
GLENMARK PHARMACEUTICALS LIMITED	32.82x	3.73x	15.86x	0.24%	6.42B
Average	23.14x	3.50x	13.47x	2%	16.87B
Weighted average by Cap.	26.74x	4.34x	16.25x	1.45%